Search for other papers by C Chiapponi in
Google Scholar
PubMed
Search for other papers by H Alakus in
Google Scholar
PubMed
Search for other papers by M Faust in
Google Scholar
PubMed
Search for other papers by A M Schultheis in
Google Scholar
PubMed
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
Search for other papers by M Schmidt in
Google Scholar
PubMed
adjuvant treatment after surgery for recurrent differentiated thyroid cancer. Eight patients (26.7%) required more than one cervical operation and in half of all cases, the MDET recommended external beam radiation therapy for adjuvant treatment after
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Mubashir Mulla in
Google Scholar
PubMed
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Department of Endocrine Surgery, King College London, King's Health Partners, King's College Hospital, Denmark Hill, London, SE5 9RS, UK
Search for other papers by Klaus-Martin Schulte in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is the most common thyroid cancer. Metastases from PTC most commonly involve the cervical lymph nodes (CLNs). The incidence of CLN metastases (CLNM) is reported between 30 and 80% (1, 2) . Some studies
Search for other papers by Keina Nishio in
Google Scholar
PubMed
Search for other papers by Akiko Tanabe in
Google Scholar
PubMed
Search for other papers by Risa Maruoka in
Google Scholar
PubMed
Search for other papers by Kiyoko Nakamura in
Google Scholar
PubMed
Search for other papers by Masaaki Takai in
Google Scholar
PubMed
Search for other papers by Tatsuharu Sekijima in
Google Scholar
PubMed
Search for other papers by Satoshi Tunetoh in
Google Scholar
PubMed
Search for other papers by Yoshito Terai in
Google Scholar
PubMed
Search for other papers by Masahide Ohmichi in
Google Scholar
PubMed
Introduction Cancer survivors are living longer after the initial diagnosis of cancer due to earlier diagnosis and improved cancer treatments. Epithelial ovarian cancer (OC), uterine endometrial cancer (EC), and cervical cancer (CC) are major
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Xu-Feng Chen in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Cong He in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Peng-Cheng Yu in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Wei-Dong Ye in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Pei-Zheng Han in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Jia-Qian Hu in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Yu-Long Wang in
Google Scholar
PubMed
clinical practice. NGS reveals the comprehensive genetic background of a certain tumor, thus assisting tumor diagnosis and treatment. Thyroid cancer is the most common endocrine malignancy with an increasing incidence ( 2 ) in recent decades. Exciting
Search for other papers by Camila Aparecida Moma in
Google Scholar
PubMed
Search for other papers by Icléia Siqueira Barreto in
Google Scholar
PubMed
Search for other papers by Ligia Vera Montali Assumpção in
Google Scholar
PubMed
Search for other papers by Denise Engelbrecht Zantut-Wittmann in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine neoplasm, corresponding to 3.4% of all malignant neoplasms diagnosed annually. About 90% are differentiated tumors derived from thyroid follicular cells ( 1 , 2 , 3 ). In recent
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
when analyzing therapeutic response. Figure 1 Flowchart indicating study inclusion and exclusion criteria. DTC, Differentiated thyroid cancer; PTC, papillary thyroid cancer; LNM, lymph node metastasis; N0, pathologically proven no cervical lymph
The First Affiliated Hospital, Department of Otorhinolaryngology, Hengyang Medical School, University of South China, Hengyang, Hunan, China
Search for other papers by Zuyao Chen in
Google Scholar
PubMed
The First Affiliated Hospital, Department of Endocrinology and Metabolism, Hengyang Medical School, University of South China, Hengyang, Hunan, China
Search for other papers by Xiaolin Zhong in
Google Scholar
PubMed
Search for other papers by Weiqiang Tang in
Google Scholar
PubMed
Search for other papers by Min Xia in
Google Scholar
PubMed
Search for other papers by Chang Liu in
Google Scholar
PubMed
Search for other papers by Yinping Guo in
Google Scholar
PubMed
Search for other papers by Yan Yi in
Google Scholar
PubMed
Search for other papers by Qingshan Jiang in
Google Scholar
PubMed
Search for other papers by Xuyu Zu in
Google Scholar
PubMed
Search for other papers by Jing Zhong in
Google Scholar
PubMed
invasion in several types of malignant tumors, such as ovarian cancer ( 8 ), squamous cell carcinoma of the oral cavity ( 9 ), and colorectal cancer ( 10 ). Additionally, an early study demonstrated that the expression of FGF1 was enhanced in differentiated
Department of Endocrinology, University of Manchester, School of Medical Sciences, Manchester, UK
Search for other papers by Victoria Chatzimavridou-Grigoriadou in
Google Scholar
PubMed
Department of Endocrinology, University of Manchester, School of Medical Sciences, Manchester, UK
Search for other papers by Lisa H Barraclough in
Google Scholar
PubMed
Search for other papers by Rohit Kochhar in
Google Scholar
PubMed
Search for other papers by Lucy Buckley in
Google Scholar
PubMed
Search for other papers by Nooreen Alam in
Google Scholar
PubMed
Search for other papers by Claire E Higham in
Google Scholar
PubMed
comparing the aBMD of postmenopausal women with cervical cancer treated with concurrent chemoradiotherapy and matched controls with history of hysterectomy for leiomyomas, BMD of L4, total hip (left) and greater trochanter was significantly lower in the
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Katherine A Bolton in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Kelly A Avery-Kiejda in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Elizabeth G Holliday in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by John Attia in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nikola A Bowden in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia
Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
repeat allele and increased breast cancer risk ( 26 , 39 ). However, recent reports, including several meta-analyses, have found no association between the length of this CA repeat and the risk of developing breast cancer ( 18 , 22 , 40 ). In cervical
Search for other papers by Zeming Liu in
Google Scholar
PubMed
Search for other papers by Di Hu in
Google Scholar
PubMed
Search for other papers by Yihui Huang in
Google Scholar
PubMed
Search for other papers by Sichao Chen in
Google Scholar
PubMed
Search for other papers by Wen Zeng in
Google Scholar
PubMed
Search for other papers by Ling Zhou in
Google Scholar
PubMed
Search for other papers by Wei Zhou in
Google Scholar
PubMed
Search for other papers by Min Wang in
Google Scholar
PubMed
Search for other papers by Haifeng Feng in
Google Scholar
PubMed
Search for other papers by Wei Wei in
Google Scholar
PubMed
Search for other papers by Chao Zhang in
Google Scholar
PubMed
Search for other papers by Danyang Chen in
Google Scholar
PubMed
Search for other papers by Liang Guo in
Google Scholar
PubMed
-stage among thyroid cancer patients aged 2–18 years. Moreover, there was a higher risk of metastasis in patients aged less than 15 years. Distant metastasis is considered in the clinical diagnosis and medical treatment of other cancers such as cervical ( 11